Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Curasight A/S, CVR no. 35 24 93 89 ("Curasight" or the "Company") held an extraordinary general meeting on 1 June 2021 at 11:00 (CET). Due to the COVID-19 situation, the extraordinary general meeting will be held as a completely electronic meeting without physical attendance.
The agenda for the general meeting was as follows:
1.
Election of Dr. Kirsten Drejer as new member of the board of directors
Dr. Kirsten Drejer was elected as new member of the board of directors. A list of Dr. Kirsten Drejer's management positions in other companies is enclosed as appendix 1.
2.
Miscellaneous
There were no matters to be presented.
Appendix 1
Dr. Kirsten Drejer's current board directorships and management positions
2000 - KD Invest ApS, CEO
2017 - Bioneer A/S (www.bioneer.dk), Chairman of the board
2017 - Antag Therapeutics ApS (www.antag.com), Chairman of the board
2017 - ResoTher Pharma A/S (www.resotherpharma.com), Chairman of the board
2018 - Zealand Pharma A/S (www.zealandpharma.com), Board member